XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.

XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.
A
A

Abbott

Nachrichten

Reuters - vor 2 Tagen

What to Watch in the Week Ahead and on Monday, October 14

What to Watch in the Week Ahead and on Monday, October 14 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of Minneapolis President Neel Kashkari will participate in a panel discussion at the Central Bank of Argentina's Money and Banking Conference on "Fiscal Defic
A
C
G
N
W
F
U
C
M
Reuters - vor 2 Tagen

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Oct 11 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 15-Oct-2024 AMC JBHT.O J B Hunt Transport Services Inc Q3 2024 J B Hunt Transport Services Inc Earnings Release 15-Oct-2024 AMC UAL.O United Airlines Holdings Inc Q3 2024 United Airlines Holdings Inc Earnings Release 15-Oct-2024 AMC OMC Omnicom Group
A
C
C
G
H
N
S
W
F
J
U
C
E
M
P
S
Reuters - vor 3 Tagen

Abbott Advances Pulsed Field Ablation Clinical Studies

BRIEF-Abbott Advances Pulsed Field Ablation Clinical Studies Oct 10 (Reuters) - Abbott Laboratories ABT.N : ABBOTT ADVANCES PULSED FIELD ABLATION CLINICAL STUDIES AND LAUNCHES NEW TECHNOLOGY TO SUPPORT ADVANCED CARDIAC MAPPING ABBOTT: GLOBAL FOCALFLEX TRIAL NOW UNDERWAY FOR ABBOTT'S TACTIFLEX™ DUO ABLATION CATHETER, SENSOR ENABLED™ ABBOTT: ADVISOR™ HD GRID X MAPPING CATHETER, SENSOR ENABLED™, RECEIVES U.S.
A
Reuters - vor 3 Tagen

U.S. Abbott, Gilead, Roku

U.S. RESEARCH ROUNDUP-Abbott, Gilead, Roku Oct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Abbott, Gilead and Roku, on Thursday. HIGHLIGHTS * Abbott ABT.N : JP Morgan raises target price to $135 from $125 * AIG AIG.N : JP Morgan raises to overweight from neutral * Gilead GILD.O : Raymond James raises target price to $95 from $94 * Lendingclub Corp LC.N : KBW raises to outperform from market perform * Roku Inc R
A
C
G
P
C
I
S
A
G
H
P
U
Reuters - vor 5 Tagen

Medical device makers need to 'beat or raise' for stocks to move higher, RBC says

BUZZ-Medical device makers need to 'beat or raise' for stocks to move higher, RBC says ** Analysts at RBC Capital Markets expect procedures to remain strong for remainder of the year, but see downturn in elective procedures in Q3 due to vacation schedules ** Investor sentiment will continue to play key role in how stocks respond given the high-bar,
A
Reuters - vor 1 Woche

WHO approves first mpox diagnostic test for emergency use

UPDATE 4-WHO approves first mpox diagnostic test for emergency use Updates Oct. 3 story to add company statement in paragraph 4 Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' ABT.N mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease.
A
R
L
Reuters - vor 2 Wochen

Jury urged to hold formula makers responsible for premature baby's illness

UPDATE 1-Jury urged to hold formula makers responsible for premature baby's illness Adds material from Abbott, Mead Johnson opening statements By Brendan Pierson Oct 2 (Reuters) - A lawyer for a Missouri mother on Wednesday urged jurors to hold Abbott ABT.N , Reckitt's RKT.L Mead Johnson unit and St. Louis Children's Hospital responsible for a severe intestinal illness that she says her prematurely born son developed after the hospital fed him the companies' formulas.
A
Reuters - vor 2 Wochen

Jury urged to hold formula makers responsible for premature baby's illness

Jury urged to hold formula makers responsible for premature baby's illness By Brendan Pierson Oct 2 (Reuters) - A lawyer for a Missouri mother on Wednesday urged jurors to hold Abbott ABT.N , Reckitt's RKT.L Mead Johnson unit and St. Louis Children's Hospital responsible for a severe intestinal illness that she says her prematurely born son developed after the hospital fed him the companies' formulas.
A
Reuters - vor 2 Wochen

U.S. STOCKS Dine Brands, Pinterest, Nike

BUZZ-U.S. STOCKS ON THE MOVE-Dine Brands, Pinterest, Nike Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes took a beating on Tuesday as reports of escalating tensions in the Middle East made investors sell riskier assets, with the benchmark S&P 500 hitting its lowest in over a week.
A
A
C
L
N
P
S
L
U
U
L
A
C
J
M
Reuters - vor 2 Wochen

Uptake of Dexcom's OTC glucose monitor Stelo outpaces Abbott's Lingo, Citi says

BUZZ-Uptake of Dexcom's OTC glucose monitor Stelo outpaces Abbott's Lingo, Citi says ** Brokerage Citi says early uptake of Dexcom's DXCM.O over-the-counter continuous glucose monitor Stelo is ahead of Abbott's ABT.N Lingo ** Stelo is gaining traction benefitting from an earlier launch compared to Lingo - Citi ** Adds app data points to a recovery for Dexcom, after the glucose monitor maker slashed its annual revenue forecast ** Brokerage says downloads of apps for Dexcom's continuous glucose mo
A
Reuters - vor 2 Wochen

UK's Reckitt falls after court trial over premature baby formula begins

BUZZ-UK's Reckitt falls after court trial over premature baby formula begins ** Shares of Enfamil formula maker Reckitt RKT.L down 1.15% at 4,524p ** Co's unit Mead Johnson, along with US-based Abbott ABT.N , is facing a trial over its premature baby formula causing a severe intestinal illness ** Plaintiffs argue companies failed to warn about the
A
Reuters - vor 2 Wochen

UK Stocks-Factors to watch on Oct 1

UPDATE 1-UK Stocks-Factors to watch on Oct 1 Adds new items, updates futures Oct 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0 .4%. * HALEON: Pfizer PFE.N offloaded shares worth roughly $3.26 billion in Haleon HLN.L at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said.
A
G
P
R
Reuters - vor 2 Wochen

UK Stocks-Factors to watch on Oct 1

UK Stocks-Factors to watch on Oct 1 Oct 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0.34% * HALEON: Pfizer's PFE.N stake sale in British consumer healthcare company Haleon HLN.L has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
A
P
Reuters - vor 2 Wochen

Abbott, Reckitt face trial over premature baby formula amid alarm from doctors

CORRECTED-Abbott, Reckitt face trial over premature baby formula amid alarm from doctors Corrects title of Jonathan Davis in paragraph 9, to Chief of Newborn Medicine at Tufts Medical Center Doctors fear losing access to essential formulas for premature babies Plaintiffs argue companies failed to warn about NEC risk from cow's milk-based formula By Brendan Pierson Sept 30 (Reuters) - A Missouri mother and her lawyers this week will aim to convince a jury that Abbott ABT.N , Reckitt's RKT.L Mead
A
Reuters - vor 3 Wochen

Indian shares set to open higher on US rate-cut euphoria

INDIA STOCKS-Indian shares set to open higher on US rate-cut euphoria BENGALURU, Sept 20 (Reuters) - Indian shares are set to open higher on Friday, as an outsized interest rate reduction by the U.S. Federal Reserve and the anticipation of a soft landing for the world's largest economy boosted risk appetite across global markets. The GIFT Nifty GIFc1 was at 25,523 points, as of 07:55 a.m.
A
U
Reuters - vor 3 Wochen

U.S. STOCKS Children's Place, US energy sector, retailers

BUZZ-U.S. STOCKS ON THE MOVE-Children's Place, US energy sector, retailers Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes soared on Thursday with the S&P 500 and the Dow hitting intraday record highs after the Federal Reserve kicked off its monetary easing cycle with half-a-percentage point reduction and forecast more interest rate cuts were on the hor
A
A
C
C
I
J
L
M
N
T
A
U
F
R
U
U
S
D
Reuters - vor 3 Wochen

Abbott Declares Qtrly Common Dividend Of 55 Cents/Shr

BRIEF-Abbott Declares Qtrly Common Dividend Of 55 Cents/Shr Sept 19 (Reuters) - Abbott Laboratories ABT.N : ABBOTT - DECLARED A QUARTERLY COMMON DIVIDEND OF 55 CENTS PER SHARE ABBOTT DECLARES 403RD CONSECUTIVE QUARTERLY DIVIDEND Source text for Eikon: ID:nPnbB2dYca Further company coverage: ABT.N
A
Reuters - vor 3 Wochen

Piper Sandler initiates coverage on Abbott with 'overweight' rating

BUZZ-Piper Sandler initiates coverage on Abbott with 'overweight' rating ** Brokerage Piper Sandler initiates coverage on Abbott Laboratories ABT.N with overweight rating and PT of $131 ** Says while execution has been strong, ABT shares have underperformed YTD due to the ongoing litigation related to necrotizing enterocolitis (NEC) in premature babies, which has been an overhang ** Brokerage believes the potential damages related to the lawsuit are already priced in ** Considers ABT to be "one
A
Reuters - vor 3 Wochen

U.S. Athira Pharma, Lowe's Companies, P&G

U.S. RESEARCH ROUNDUP-Athira Pharma, Lowe's Companies, P&G Sept 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Athira Pharma, Lowe's Companies and P&G on Thursday. HIGHLIGHTS * Athira Pharma Inc ATHA.O : Mizuho cuts to neutral from outperform * Five Below Inc FIVE.O : JP Morgan cuts to underweight from neutral * Lowe's Companies Inc LOW.N : TD Cowen raises target price to $265 from $240 * P&G PG.N : JP Morgan rai
A
A
C
D
M
N
T
A
C
Reuters - vor 4 Wochen

India's pharma index climbs after bumper Fed rate cut

BUZZ-India's pharma index climbs after bumper Fed rate cut ** India's Nifty pharma index .NIPHARM climbs 0.5%, snapping three straight sessions of losses ** Rise after the U.S. Federal Reserve started its monetary easing cycle with a large 50-basis-point rate cut MKTS/GLOB ** Indian pharma firms have a sizeable exposure to U.S. markets and earn a significant share of their rev from the geography ** Eighteen of the 21 index constituents are trading in green; top gainers Abbott India ABOT.NS and A
A

Konditionen

Beliebte Finanzwerte

Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.

Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.

Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.

Risikowarnung: Es bestehen Risiken für Ihr eingesetztes Kapital. Gehebelte Produkte sind nicht für alle Anleger geeignet. Bitte beachten Sie unseren Risikohinweis.